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ABSTRACT
The integration of patient/person generated health data into clinical applications is 
a widespread aspiration internationally. However, there is still a range of challenges 
that inhibit progress in this area. These include technology-related factors (such 
as interoperability), use-related factors (such as data overload) and characteristics 
of the strategic environment (such as existing standards). Building on important 
policy deliberations from the United States that aim to navigate these challenges, 
we here apply emerging policy frameworks to the United Kingdom and outline five 
key priority areas that are intended to help policymakers make important strategic 
decisions in attempting to integrate patient/person generated data into electronic 
health records.
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INTRODUCTION
Internationally, there is an increasing focus on digital data 
to improve healthcare quality, safety and efficiency.1 A wide 
range of technological applications is being developed daily 
and these generate increasing amounts of health- and well-
ness-related data. Many portable devices (such as apps and 
wearables) allow the collection of data generated by patients. 
Such data are commonly known as patient/person generated 
health data (PGHD) and may include not only clinical data 
(such as blood pressure readings) but also a recording of 
patient/person reported outcome measures, history, activity, 
preferences and values.2–4
In addition to benefiting patients and carers even if not 
shared, there is an increasing realisation that such data 
can inform public health and clinical decision making and 
increase patient involvement.5,6 Empirical evidence shows 
that at least in some conditions (e.g. diabetes and high blood 
pressure), clinicians collecting and acting on patient accrued 
data improve outcomes in cost-effective ways.7 Yet, despite 
some progress in specific conditions and settings, the inte-
gration of such data with provider-facing technologies – in 
particular, electronic health records (EHRs) – is still aspira-
tional.8–10 Where such integration has been achieved, it has 
proved popular with clinicians.11 In the UK, although there 
is a policy drive to have PGHD linked to EHRs and facilitate 
patient access to their personal health records,12–14 national 
strategic direction to achieve such effective integration is cur-
rently lacking focus.
There is significant potential in learning from other coun-
tries who are now actively pursuing development of PGHD-
related strategies and infrastructures.15
METHODS
We here aim to provide a starting point for these delibera-
tions by distilling key strategic priorities for developing a more 
integrated national approach. To achieve this, we build on 
recent work conducted by the American Medical Informatics 
Association (AMIA) exploring potential policy frameworks and 
associated strategies for PGHD,16 and a white paper for a 
PGHD Policy Framework published by the U.S. Department 
of Health and Human Services’ Office of the National 
Coordinator (ONC) for Health Information Technology in col-
laboration with Accenture.15 North American deliberations 
were the focus of this work as they are relatively advanced 
in national policy deliberations in relation to PGHD. We sum-
marise five key priority areas emerging from these frame-
works and place these in the UK context to illustrate how 
national strategy can build on existing challenges, initiatives, 
technologies, expertise and infrastructures. The list of priority 
areas is not intended to be exhaustive and we acknowledge 
that areas may overlap. Challenges and recommendations 
are summarised in Figure 1.
Figure 1 Illustration of existing challenges and associated key strategic priority areas
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Priority 1: Creating regulatory environments 
that promote information integration across 
data sources without stifling innovation
PGHD may be viewed as an addition to existing health infor-
mation infrastructures that are built, created and maintained 
by a variety of stakeholders, including patients themselves.17 
Developing data standards that enable structured data entry 
and information sharing across various applications is key to 
achieving a degree of information integration across informa-
tion systems.
Since April 2017, the national governance arrangements 
for information standards in healthcare, data collections 
and data extractions in the UK are overseen by the Data 
Coordination Board. There is now also an NHS Digital Apps 
Library with NHS approved patient facing functionality.18 
However, although some progress has been made in rela-
tion to creating unique patient identifiers and developing 
data standards in clinical applications, there are currently 
no national or international standards that promote the 
exchange of information between PGHD applications and 
EHRs. This may partly be due to the reluctance of develop-
ers to open up their systems to third-party suppliers, limiting 
seamless exchange between mobile devices and EHRs.19 
Many developers address international markets and there 
is substantial variation in the structure of health care sys-
tems, legal requirements and the interoperability afforded by 
the EHR systems in use. Hence, sharing the PGHD is often 
limited to emailing information to relevant stakeholders, be 
they doctors, carers or family members. As a result, existing 
health-related data are held in silos and there is, therefore, 
now an increasing international drive to open up Application 
Programming Interfaces (APIs).20 The newly established API 
Lab run in partnership between NHS Digital and INTEROPen 
and the Substitutable Medical Applications, Reusable 
Technologies on Fast Healthcare Interoperability Resources 
open specifications to integrate health information technol-
ogy systems is likely to present an important national first 
step towards addressing this issue.21,22 Going forward, the 
adoption of internationally accredited standards is critical in 
order to incentivise developers and minimise variation across 
settings. Although regional variations are likely to exist, such 
standards can facilitate the implementation of core software 
capabilities that can facilitate data exchange.
As PGHD is an emerging area, there are also currently 
no clear liability laws surrounding patient facing devices 
and approval mechanisms are convoluted, which may fur-
ther prevent developers from actively pursuing strategies to 
integrate patient facing technologies with clinical systems.23 
This may also prevent healthcare professionals from using 
these data. In the European Union, apps that transmit clini-
cal information are currently classed as medical devices and 
need approval by the Medicines and Healthcare products 
Regulatory Agency – a very lengthy process.24,25 In terms of 
the development of clinical apps, the normal industry practice 
of rapid prototype development with iterative cycles does not 
fit well with ethical requirements, which for patient apps need 
precise descriptions of technology for approval. Streamlining 
these mechanisms will, therefore, be critical in stimulating a 
vibrant ecosystem, whilst appropriately regulating approvals, 
liability and data sharing.
Priority 2: Developing data governance and 
ethical frameworks that allow data sharing 
across settings
In relation to PGHD, there is at present no coordinated frame-
work for data sharing across agencies and settings due to 
infrastructural considerations discussed above. Current UK 
data protection frameworks are designed to regulate data 
access and sharing of medical information in clinical applica-
tions26 but these now need to be extended to cover a range 
of patient facing technologies and associated PGHD that will 
move between individuals, settings and technologies. These 
frameworks need to be sufficiently flexible. For instance, 
existing guidelines treat all healthcare data equally although 
not all data are equally sensitive, for example, patient activity 
levels.27 Frameworks also need to ensure a balance between 
patient data being kept safe and adequately protected, whilst 
still promoting data liquidity.
There is further an urgent international need to develop 
robust ethical frameworks, closely aligned to legal frameworks, 
for emerging medical technologies and associated PGHD. 
Establishing a national ethics working group will be important, 
working collaboratively with system developers to anticipate 
emerging ethical challenges and mitigating potential risks early.
Priority 3: Standardising person-centred 
methods and outcomes
In the face of questions surrounding the validity and accu-
racy of some PGHD devices and the emerging nature of 
efforts to incorporate PGHD with EHRs, there is an important 
need to strengthen the empirical evidence base surrounding 
various applications.16,28,29 In order to aggregate evidence 
and align with different functionalities, outcome measures 
should where possible be standardised and build on exist-
ing national work surrounding, for example, Patient Reported 
Outcome Measures led by NHS Digital.30 Here, initial efforts 
could focus on building an evidence base surrounding the 
most commonly used functionalities (e.g. apps) and condi-
tions, where PGHD has been tested in small-scale pilots (e.g. 
asthma, diabetes).8,9,31
This work needs to ensure appropriate coverage surround-
ing patients, in order to define core datasets that are relevant 
to specific health outcomes, and clinician-informed, in order 
to ensure that information generated by patients is used by 
clinicians (see Priority 4 below). Drawing on theory-informed 
approaches to evaluation will be extremely important in this 
context, in order to learn from experience and generalise 
between settings and across conditions.32 Such work should 
also draw and build on ongoing international evaluation efforts.
Priority 4: Incentives for various 
stakeholders to create, use and re-use PGHD
In order for PGHD to be created, used and re-used effectively, 
it is important to map benefits and challenges across different 
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stakeholders.15 These mapping exercises must be more 
closely aligned with efforts to develop an empirical evidence 
base and also with health system structure, ensuring that 
generation and use of PGHD are appropriately incentivised.
Patients need to be motivated to continuously gener-
ate PGHD that are perceived to be useful to clinical users. 
While education matters, it is even more important that 
patients perceive PGHD to be useful and meaningful for 
themselves. More active promotion of incentives amongst 
less motivated users may also help. Such efforts could build 
on existing work surrounding perceived valuable features of 
mobile applications among the general population in order 
to promote lasting behaviour change.33 These may include 
repeat prescription ordering, appointment making and/or 
gamification techniques.
Clinicians need to be incentivised to draw on data gener-
ated by patients and this can only be achieved by developing 
tools that integrate effectively with existing workflows and that 
produce data that can be translated into meaningful informa-
tion that is helpful at the point of care (see Priority 5 below).
Developers need to be incentivised (or forced if inter-
facing with the NHS) to open APIs (as discussed above) 
and develop tools that make it easy for patients, clinicians 
and researchers to produce, use and re-use PGHD. They 
need to want to create patient-facing applications that are 
designed to integrate with clinical systems, whilst still mak-
ing a financial profit. This is particularly true in increasingly 
regulated international environments, where incentives will 
need to match suppliers’ level of effort required to navigate 
these challenges.
Regulatory environments can stifle development in this 
respect and it is, therefore, crucial that strategic frameworks 
remain flexible and responsive to emerging needs.34 Here, it 
also needs to be kept in mind that there are many challenges 
with the development of open APIs, including risks surrounding 
the breaking of application functionality with the introduction of 
new interfaces or features, increased security risks and secu-
rity complexity, unexpected/undocumented releases and the 
support needed for this increased complexity. There are further 
potential risks associated with data protection and these need 
to be carefully tracked and incorporated in emerging regulatory 
frameworks (see Priority 2).
Priority 5: Collaboration across stakeholder 
groups to create tools that work for all
Patient and provider facing technologies need to be usable 
as otherwise they will be rejected or used in a way that do 
not yield sufficient high-quality data used in other ways than 
intended, leading to potentially adverse consequences for 
patients and professionals.35 However, existing EHRs have 
been found to lack usability/integrability and often have diffi-
culty integrating effectively with healthcare professional work 
practices.36 The development of technology, therefore, needs 
to be informed by user-centred design principles and this 
requires close collaboration between stakeholders (develop-
ers, patients and clinicians) to ensure that information is col-
lected and presented in a format that aligns with user needs.37
Information presentation of PGHD in clinical systems is 
likely to pose the biggest challenge, as clinical users can feel 
overwhelmed being presented with large amounts of unsolic-
ited data in electronic systems, which may distract clinicians 
and result in patient harm.38–40 This is complicated by the 
variety of stakeholders and different resulting data needs – 
each provider will need different contextualised information 
depending on the task at hand.16
Currently, most data from patient-facing devices are pre-
sented in PDF format which clinicians can open when/if they 
feel appropriate. However, this means that important oppor-
tunities for intervention may be missed. It is, therefore, critical 
to draw on the existing human factors literature to build an 
evidence base surrounding technical functionality and asso-
ciated perceived value to individual users across settings.40 
Work surrounding alert fatigue in clinical decision support 
systems may also offer valuable insights in relation to design-
ing information presentation.41 There is also an urgent need 
for summarised data which can be presented periodically 
through normal data management channels (e.g. like lab 
results and letters currently are), which are harder to ignore 
by clinical users.
Ideally, the way information is presented is flexible and 
sensitive to individual contexts/roles so that different clini-
cal users only see patient-generated information they need 
for the task at hand. In this respect, establishing processes 
for when information is displayed in clinical systems can be 
extremely helpful and this has international relevance. For 
example, PGHD may be most appropriately selectively pre-
sented to clinicians when the patient experiences exacerba-
tions or in different levels of abstraction that can be selected 
according to individual needs/preferences. In this respect, 
machine learning may facilitate self-management (e.g. by 
helping patients to make decisions as to when to consult a 
clinician) and it may also help to tailor insights from data to 
roles of clinical users.
CONCLUSIONS
Although an international priority, the integration of PGHD into 
EHRs is still largely aspirational. Building on important ground-
work by AMIA and ONC, we have discussed the need to con-
sider several strategic priorities for UK healthcare policy that we 
hope will help guide policymakers when embarking on larger 
scale efforts to promote the use of PGHD in clinical settings. 
Here, balancing a degree of flexibility in regulation/governance 
with promoting the development of usable tools that generate 
information that is viewed as valuable for use and re-use is 
likely to determine how easily strategic aims are achieved.
Such deliberations need to be followed by exploring the 
two-way flow of information into and out of the EHR – so that 
data collected by either the patient or the health service is 
available in suitable ways to both the patient and the health-
care professionals in a useful and actionable form. They also 
need to be regularly updated in light of national and interna-
tional developments both within the UK and North American 
settings, but also in relation to other European countries.
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